IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 369 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $599,000 | -78.8% | 10,595 | -82.2% | 0.06% | +106.7% |
| Q3 2020 | $2,830,000 | -87.0% | 59,663 | -83.8% | 0.03% | -84.9% |
| Q2 2020 | $21,778,000 | +1348.0% | 369,381 | +1060.4% | 0.20% | +1321.4% |
| Q1 2020 | $1,504,000 | -18.3% | 31,831 | +3.5% | 0.01% | +27.3% |
| Q3 2019 | $1,842,000 | -62.2% | 30,748 | -59.4% | 0.01% | -56.0% |
| Q2 2019 | $4,873,000 | – | 75,817 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sicart Associates LLC | 367,360 | $14,768,000 | 10.67% |
| BB BIOTECH AG | 7,461,295 | $299,944,000 | 9.81% |
| TANAKA CAPITAL MANAGEMENT INC | 83,399 | $3,353,000 | 7.39% |
| DOWLING & YAHNKE LLC | 675,843 | $27,169,000 | 2.89% |
| Opus Point Partners Management, LLC | 78,900 | $3,172,000 | 2.35% |
| Motley Fool Asset Management LLC | 259,000 | $10,412,000 | 2.25% |
| ARK Investment Management | 127,563 | $5,128,000 | 1.48% |
| Motley Fool Wealth Management, LLC | 325,965 | $13,104,000 | 1.26% |
| PINNACLE ASSOCIATES LTD | 1,514,710 | $60,891,000 | 1.16% |
| Bellevue Group AG | 205,253 | $8,251,000 | 1.10% |